[ Price : $8.95]
FDA accepts for priority review a Bristol Myers Squibb supplemental BLA for Breyanzi (lisocabtagene maraleucel; liso-cel) as a pot...[ Price : $8.95]
FDA accepts a Lantheus NDA for a new formulation of its Pylarify F 18 prostate-specific membrane antigen imaging agent.[ Price : $8.95]
FDA publishes the FY 2025 Quarter 2 update to the CBER/CDER Data Standards Program Action Plan.[ Price : $8.95]
FDA grants Clarametyx Biosciences both fast track and qualified infectious disease product designations for its lead therapeutic c...[ Price : $8.95]
FDA warns Italys Mectronic Medicale about Quality System, Medical Device Reporting, and other violations in its illegal manufactur...[ Price : $8.95]
FDAs Oncology Center of Excellence announces a two-day virtual public workshop to advance the development of patient registries in...[ Price : $8.95]
FDA warns Glendora, CA-based Oasis Medical about CGMP violations in its production of finished drugs.[ Price : $8.95]
Right-wing commentator Laura Loomer publicly criticizes FDA commissioner Marty Makary over recent comments surrounding the departu...